arrow
N

Neil P. Grimster

oncology r&d, astrazeneca, waltham, ma 02451, usa
H指数:21
被引数:3,930

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Synthetic chemistry enabling the discovery and development of a series of pyrazoles as HPK1 inhibitors

合成化学使一系列作为HPK1抑制剂的吡唑的发现和开发成为可能

2025-08-140
PRE
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor

吡嗪羧酰胺AZ3246的发现与优化:一种选择性HPK1抑制剂

2025-02-102
PRE
Accelerated Discovery of Carbamate Cbl-b Inhibitors Using Generative AI Models and Structure-Based Drug Design
2024-08-120
PRE
Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors
2024-01-163
PRE
Discovery of a Novel Benzodiazepine Series of Cbl-b Inhibitors for the Enhancement of Antitumor Immunity
2023-11-176
OA
Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization
2023-09-223
PRE
Discovery of (2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor

发现 (2R)-N-[3-[2-[(3-甲氧基-1-甲基-吡唑-4-基) 氨基] pyrimidin-4-yl]-1h-吲哚-7-基]-2-(4-甲基哌嗪-1-基) 丙烯酰胺 (AZD4205) 作为有效和选择性的Janus激酶1抑制剂

2020-04-1639
PREAI
Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase Inhibitors
2018-06-0117
PREAI